Company intelligence / Profile preview

The iQ Group Global

Sydney, New South Wales, Australiatheiqgroupglobal.com ↗
Ownership
Private
Employees
~200
Development stage
Other
01

Overview

Developing biosensor diagnostics (e.g., saliva glucose) about to commence clinical trials and oncology compounds (e.g., OxaliTEX) commencing clinical trials for platinum-resistant ovarian cancer.

Industry
Biotech
02

Partnerships

Harvard University Wyss InstituteUniversity of Texas

Beyond the preview

Go deeper on The iQ Group Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on The iQ Group Global.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call